Royal DSM : DSM concludes acquisition of outstanding shares in DSM-AGI

DSM issued a public tender offer to purchase the remaining shares of DSM-AGI Corporation via one of its affiliates on 3 March 2017. This process has now been completed and the company has been de-listed from the Taipei stock exchange.

DSM originally acquired a 51% stake in DSM-AGI in July 2011 to strengthen the UV-curing technology platform for DSM Resins & Functional Materials. Making DSM-AGI a wholly-owned subsidiary will allow DSM to more effectively integrate DSM-AGI's operations and management within its own global organization. Fully leveraging DSM's operational expertise and R&D capabilities is expected to enhance DSM-AGI's global competitiveness and allow it to better respond to current and future developments in its industry.

Patrick Niels, President of DSM Resins & Functional Materials, commented: 'UV-curing coating systems are among the most sustainable coating technologies on the market. The acquisition of the outstanding shares underlines DSM's commitment to create a leading position in UV resins, alongside its leading global position in powder coating and waterborne resins. UV resins are in high demand for use in highperformance, low-eco footprint and high efficiency coating applications as well as for specialty applications such as for use in fiber optic coatings. Driving the transition to more sustainable technologies from our leading global market positions has been and will remain a clear growth driver for DSM and a clear value driver for our industry partners.'

DSM - Bright Science. Brighter Living.™

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.